
UB432
TargetsTLR9
IndicationsPeritoneal carcinomatosis; Solid tumour
ClinicalUS - Preclinical
TherapeuticsOncology
ModalitiesPolysaccharide
Asset Materials

How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →